SPARK Europe Webinar Series | Dr. Edgar Specker "High Throughput Screening at EU-OPENSCREEN"

Abstract

Are you looking for an open access compound library to perform high-throughput screening (HTS)?

If your drug discovery project is at a stage in which you need to identify hits and optimize them, then you will be searching for the optimal compound libraries and HTS platforms.

In this SPARK Europe Webinar, Dr. Edgar Specker, a medicinal chemist (Bayer, Zedira, Jerini) with over 10 years of experience as compound library manager will present to us the European screening network EU-OPENSCREEN which integrates high-capacity screening platforms with a specially selected and unique 100.000 compound collection. The library is centrally stored at the EU-OPENSCREEN laboratories in close collaboration with the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin.

Access to the EU-OPENSCREEN resources is especially open to researchers from academia and industry of the EUROPEAN research community.

After this talk, you will know about:

• Why and how to perform your HTS at EU-OPENSCREEN and at the FMP?
• How to select the right compound library?
• What are EU-OPENSCREEN’s Europe-wide services and resources?
• How to prioritize and optimize your hit list?

SPARK Europe Webinar Series

The webinar series is organized by the different SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv.

The series covers topics from design thinking to challenges in selling complex high-tech products from top-quality speakers around Europe and the US.

The online lectures take place once per month on Wednesday at 4-5 pm CET, and are open for all students and employees of SPARK associated organizations.

About SPARK-BIH and SPARK Europe

SPARK is an initiative created at Stanford University, to overcome challenges associated with translation of academic discoveries.

SPARK-BIH is located in Berlin and supports academic inventors with tailored education, mentorship and funding. The purpose of the program is to de-risk projects with high potential impact and accelerate the translation of academic inventions into outstanding medical products including drugs, diagnostics and medical devices.

SPARK Europe is the joint network of SPARK sites all over Europe plus Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. It aims to fulfill SPARK’s mission of improving human health by uniting academics and industry experts around the globe to generate an efficient, effective and exciting pathway for the translation of academic discoveries and innovative solutions through education and project support.